| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50080 |
NCTC clone 1469 |
mouse |
liver |
The NCTC clone 1469 is a subline of NCTC 721. |
|
| 2 | general cells |
IFO50107 |
G-292 clone A141B1 |
human |
bone |
osteosarcoma |
|
| 3 | general cells |
IFO50269 |
GH1 |
rat |
pituitary gland |
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) |
|
| 4 | general cells |
IFO50271 |
HUV-EC-C |
human |
umbilical cord, vein |
Normal endothelial cells with limited life span. For cultivation, endothelial cell growth supplement can be substituted by ca 10 ng/ml basic FGF. |
|
| 5 | general cells |
IFO50277 |
5RP7 |
rat |
embryo |
fibroblast transformed by c-Ha-ras oncogene |
|
| 6 | general cells |
IFO50303 |
T98G |
human |
brain |
glioblastoma, multiforme |
|
| 7 | general cells |
IFO50368 |
no.10 |
human |
brain |
Human anaplastic glioma cell line derived from brain. |
|
| 8 | general cells |
JCRB0120 |
YG10007 |
hamster, Chinese |
lung |
human monomorphic N-acetyltransferase gene introduced CHL cells |
|
| 9 | general cells |
JCRB0132.2 |
AH601.P3(JTC27) |
rat |
acites |
AH-601 cell line adapted to a serum free medium. |
|
| 10 | general cells |
JCRB0143.6 |
F2408 EBNA2 cl-23 |
rat |
whole body of embryo |
This cell line is one of a series of F2408 rat cell lines with recombinant plasmid pZE2 with coding region of the EBNA2 transfected, but the expression of the EBNA2 was weak in this strain. |
|
| 11 | general cells |
JCRB0146 |
MLMA |
human |
peritoneal effusion |
The cells are IgD, IgM positive, hairy B-cells from human malignant lymphoma patient. |
|
| 12 | general cells |
JCRB0158.0 |
MY |
human |
peripheral blood |
Human bone marrow mononuclear cells derived from a patient having acute biphenotypic leukemia. |
|
| 13 | general cells |
JCRB0194 |
KON |
human |
cervical lymph node |
Human squamous carcinoma cell line from oral floor. |
|
| 14 | general cells |
JCRB0408 |
Ac2F |
rat |
liver |
normal liver, diploid, (Donryu rat) |
|
| 15 | general cells |
JCRB0538 |
TIG-109 |
human |
skin |
Normal diploid human skin cells. |
|
| 16 | general cells |
JCRB1090 |
NCE 16IIA |
human |
cervix |
HPV16 transformed noraml cells derived from human cervix. |
|
| 17 | general cells |
JCRB1190 |
NCC-RbC-57 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. |
|
| 18 | general cells |
JCRB1193 |
HEC-1-B |
human |
uterine corpus |
Endometrioid adenocarcinoma (G2) from human uterus body. |
|
| 19 | general cells |
JCRB1314 |
HPSV178-4-3 |
mouse |
|
Hybridoma cell line producing mAb HPSV178, against the C-terminal portion of PrPSV (residues 214-230). |
|
| 20 | general cells |
JCRB1342.12 |
MOR44.4.1 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 21 | genetically-modified cells |
JCRB1371 |
GS-3A4-HepG2 |
human |
Liver |
Human glutamine synthetase gene and drug-metabolizing CYP3A4 gene introduced Hep G2 cells. |
|
| 22 | general cells |
JCRB1410 |
Kasumi-10 |
human |
blood |
B cell leukemia [Cultivation is considerably difficult] |
|
| 23 | general cells |
JCRB1453 |
CLAC |
dog |
lung |
Canine lung adenocarcinoma cell line including cancer stem cells (0.75%) in sidepopulation (SP). |
|
| 24 | general cells |
JCRB1632 |
VV-1H831 |
mouse x mouse |
|
Mouse hybridoma producing mAb (IgG1) to hemagglutinine (HA) of vaccinia virus. |
|
| 25 | general cells |
JCRB1814 |
Mutu III |
human |
blood |
Burkitt lymphoma derived B cell line latently infected with EBV (type III latency) |
|
| 26 | general cells |
JCRB1856 |
NALM-37 |
human |
peripheral bood |
B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-36 |
|
| 27 | genetically-modified cells |
JCRB1969 |
MDCK-TKO |
dog |
kidney |
Epidermal growth factor (EGF), heparin-binding EGF (HBEGF), and transforming growth factor alpha (TGFalpha)-triple deficient MDCK cell line. |
|
| 28 | general cells |
JCRB1997 |
UCCA-25 |
human |
primary rectum carcinoma |
Derived from colorectal cancer with ulcerative colitis. Isolated as adenosquamous carcinoma of the adenomas by cloning. |
|
| 29 | general cells |
JCRB2221 |
A9(Hygro21) |
human chromosome-introduced |
skin |
contains human chromosome #21 (MTA with Tottori Univ. is required.) |
|
| 30 | general cells |
JCRB9050 |
IMR-32 |
human |
neuroblastoma arising at abdomen |
Human neuroblastoma cell line. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.